216 related articles for article (PubMed ID: 8783808)
1. Therapeutic basis of glycyrrhizin on chronic hepatitis B.
Sato H; Goto W; Yamamura J; Kurokawa M; Kageyama S; Takahara T; Watanabe A; Shiraki K
Antiviral Res; 1996 May; 30(2-3):171-7. PubMed ID: 8783808
[TBL] [Abstract][Full Text] [Related]
2. Effects of glycyrrhizin on hepatitis B surface antigen: a biochemical and morphological study.
Takahara T; Watanabe A; Shiraki K
J Hepatol; 1994 Oct; 21(4):601-9. PubMed ID: 7814808
[TBL] [Abstract][Full Text] [Related]
3. [The pharmacokinetics of the glycyrrhizin and glycyrrhetic acid after intravenous administration of glycyrrhizin for the patients with chronic liver disease caused by type C hepatitis virus].
Takahashi M; Nakano S; Takeda I; Kumada T; Sugiyama K; Osada T; Kiriyama S; Toyoda H; Shimada S; Samori T
Nihon Shokakibyo Gakkai Zasshi; 1995 Dec; 92(12):1929-36. PubMed ID: 8558777
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhetic acid, but not glycyrrhizic acid, strengthened entecavir activity by promoting its subcellular distribution in the liver via efflux inhibition.
Chen Q; Chen H; Wang W; Liu J; Liu W; Ni P; Sang G; Wang G; Zhou F; Zhang J
Eur J Pharm Sci; 2017 Aug; 106():313-327. PubMed ID: 28627473
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis.
Takeda S; Ishthara K; Wakui Y; Amagaya S; Maruno M; Akao T; Kobashi K
J Pharm Pharmacol; 1996 Sep; 48(9):902-5. PubMed ID: 8910850
[TBL] [Abstract][Full Text] [Related]
6. Intestinal bacterial hydrolysis is indispensable to absorption of 18 beta-glycyrrhetic acid after oral administration of glycyrrhizin in rats.
Akao T; Hayashi T; Kobashi K; Kanaoka M; Kato H; Kobayashi M; Takeda S; Oyama T
J Pharm Pharmacol; 1994 Feb; 46(2):135-7. PubMed ID: 8021802
[TBL] [Abstract][Full Text] [Related]
7. Effect of paeoniflorin, glycyrrhizin and glycyrrhetic acid on ovarian androgen production.
Takeuchi T; Nishii O; Okamura T; Yaginuma T
Am J Chin Med; 1991; 19(1):73-8. PubMed ID: 1897494
[TBL] [Abstract][Full Text] [Related]
8. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro.
Crance JM; Lévêque F; Biziagos E; van Cuyck-Gandré H; Jouan A; Deloince R
Antiviral Res; 1994 Jan; 23(1):63-76. PubMed ID: 8141593
[TBL] [Abstract][Full Text] [Related]
9. In vitro antiviral activity of indigenous glycyrrhizin, licorice and glycyrrhizic acid (Sigma) on Japanese encephalitis virus.
Badam L
J Commun Dis; 1997 Jun; 29(2):91-9. PubMed ID: 9282507
[TBL] [Abstract][Full Text] [Related]
10. Research Progress of Glycyrrhizic Acid on Antiviral Activity.
Sun ZG; Zhao TT; Lu N; Yang YA; Zhu HL
Mini Rev Med Chem; 2019; 19(10):826-832. PubMed ID: 30659537
[TBL] [Abstract][Full Text] [Related]
11. Glycyrrhizin withdrawal followed by human lymphoblastoid interferon in the treatment of chronic hepatitis B.
Hayashi J; Kajiyama W; Noguchi A; Nakashima K; Hirata M; Hayashi S; Kashiwagi S
Gastroenterol Jpn; 1991 Dec; 26(6):742-6. PubMed ID: 1765247
[TBL] [Abstract][Full Text] [Related]
12. Differences in the metabolism of glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid monoglucuronide by human intestinal flora.
Akao T
Biol Pharm Bull; 2000 Dec; 23(12):1418-23. PubMed ID: 11145169
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of interferon-gamma production in glycyrrhizin-treated human peripheral lymphocytes in response to concanavalin A and to surface antigen of hepatitis B virus.
Shinada M; Azuma M; Kawai H; Sazaki K; Yoshida I; Yoshida T; Suzutani T; Sakuma T
Proc Soc Exp Biol Med; 1986 Feb; 181(2):205-10. PubMed ID: 3080754
[TBL] [Abstract][Full Text] [Related]
14. Protection of liver cells from experimentally induced liver cell injury by glycyrrhizin.
Mizoguchi Y; Katoh H; Tsutsui H; Yamamoto S; Morisawa S
Gastroenterol Jpn; 1985 Apr; 20(2):99-103. PubMed ID: 4029553
[TBL] [Abstract][Full Text] [Related]
15. [Effects of glycyrrhizin on the expression of hepatitis B virus and Toll like receptors 2,4 in HepG2.2.15 cells expressing low HBsAg].
Li YW; Yang HZ; Ke QS; Chen W; Chen XJ
Zhong Yao Cai; 2008 Mar; 31(3):403-7. PubMed ID: 18619248
[TBL] [Abstract][Full Text] [Related]
16. A new anti-human immunodeficiency virus substance, glycyrrhizin sulfate; endowment of glycyrrhizin with reverse transcriptase-inhibitory activity by chemical modification.
Nakashima H; Matsui T; Yoshida O; Isowa Y; Kido Y; Motoki Y; Ito M; Shigeta S; Mori T; Yamamoto N
Jpn J Cancer Res; 1987 Aug; 78(8):767-71. PubMed ID: 2443473
[TBL] [Abstract][Full Text] [Related]
17. Antiviral activity of recombinant interferon-alpha on hepatitis A virus replication in human liver cells.
Crance JM; Lévêque F; Chousterman S; Jouan A; Trépo C; Deloince R
Antiviral Res; 1995 Sep; 28(1):69-80. PubMed ID: 8585761
[TBL] [Abstract][Full Text] [Related]
18. An antigranulomatous effect of glycyrrhizin.
Matsushima Y; Baba T
J Exp Pathol; 1992; 6(1-2):25-30. PubMed ID: 1625037
[TBL] [Abstract][Full Text] [Related]
19. Sweetness of glycyrrhetic acid 3-O-beta-D-monoglucuronide and the related glycosides.
Mizutani K; Kuramoto T; Tamura Y; Ohtake N; Doi S; Nakaura M; Tanaka O
Biosci Biotechnol Biochem; 1994 Mar; 58(3):554-5. PubMed ID: 7764694
[TBL] [Abstract][Full Text] [Related]
20. Effect of pH on metabolism of glycyrrhizin, glycyrrhetic acid and glycyrrhetic acid monoglucuronide by collected human intestinal flora.
Akao T
Biol Pharm Bull; 2001 Oct; 24(10):1108-12. PubMed ID: 11642312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
